No Detail Found!

Importance of measuring non-HDL cholesterol in type 2 diabetes patients.

Author(s)
Nanik Ram Section of Endocrinology, Department of Medicine, Aga Khan University, Karachi, Pakistan
Bilal Ahmed Eidemiology and Biostatistics, Department of Medicine, Aga Khan University, Karachi, Pakistan
Fauzan Hashmi Section of Endocrinology, Department of Medicine, Aga Khan University, Karachi, Pakistan
Abdul-Jabbar Section of Endocrinology, Department of Medicine, Aga Khan University, Karachi, Pakistan
Abstract
Objective: To study the correlation between Non-high-density liporotein and low-density liporotein cholesterol in patients with Type 2 diabetes mellitus and the proportion of patients achieving Adult Treatment panel III recommended goals. Methods: The cross sectional study was conducted at the Diabetic Clinic, Aga Khan University Hosital, Karachi. Data of Type 2 diabetes mellitus patients who attended the clinic between 2007 and 2011 was reviewed. All Type 2 diabetic patients of either gender with fasting lipid profile irrespective of taking lipid lowering therapy were included. Tye-1 DM, gestational diabetes, type 2 diabetes patients withp regnancy and those with incomplete data were excluded. Correlation between the low-density liporotein and Non- high-density liporotein was assessed by applying Cramer V and hi. proportion of patients achieving Adult Treatment panel III recommended goals was checked. Multivariable regression was done to identify common factors associated with elevated Non- high-density liporotein cholesterol. Results: A total of 1352 patients fulfilling the eligibility criteria were included in the study. Mean age of the patients was 54.5±11.3 years; 797 (59%) were males; 1122 (83%) had Body Mass Index above 25; and 1016 (75%) had HbA1c >7%. Mean Non-high-density liporotein cholesterol was 129±42mg/dl. Mean low-density liporotein cholesterol was 100±37mg/dl. Both low-density liporotein 130mg/dl (100mg/dl was independently associated with having Non-high-density liporotein cholesterol >130mg/dl (Adjusted Odds Ratio 38.6; 95% Confidence Interval = 28.1-53.1). Similarly, age 130 mg/dl (Adjusted Odds Ratio 1.6; 95% Confidence Interval = 1.01 - 2.3). Whereas having obesity Body Mass Index >25 was 3.6 times more associated to have Non-high-density liporotein >130mg/dl (Adjusted Odds Ratio 3.6; 95% Confidence Interval = 1.6-7.7). In patients with coronary artery disease, combined goal achievement of low-density liporotein 100mg/dl (p
Publication Details
Page(s) 124-128
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 64, Issue: 2, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

135

Views